Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLUTASIDENIB vs OMADACYCLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OLUTASIDENIB vs OMADACYCLINE: Safety Overview

Metric OLUTASIDENIB OMADACYCLINE
Total FAERS Reports 210 1,079
Deaths Reported 27 79
Death Rate 12.9% 7.3%
Hospitalizations 85 231
Average Patient Age 66.2 yrs 60.8 yrs
% Female Patients 46.3% 55.1%
FDA Approval Date Dec 1, 2022 Oct 2, 2018
Manufacturer Rigel Pharmaceuticals, Inc. Paratek Pharmaceuticals, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription